ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITORS (ARNI) POTENTIALS IN PATIENT WITH HEART FAILURE: A SYSTEMATIC REVIEW

被引：0
|
作者：
Puratmaja, Nalagafiar [1 ]
Sjarfi, Cheras Yezia Kharismia [2 ]
机构：
[1] Cijulang Community Hlth Ctr, Pangandaran, Indonesia
[2] Mampang Prapatan Reg Gen Hosp, South Jakarta, Indonesia
来源：
JOURNAL OF HYPERTENSION | 2020年 / 38卷
关键词：
angiotensin receptor-neprilysin inhibitors; enalapril; heart failure; sacubitril/valsartan;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
3-10
引用
收藏
页码：E7 / E7
页数：1
相关论文
共 50 条
  • [1] Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists
    Dalal, Jamshed
    Chandra, Praveen
    Ray, Saumitra
    Hazra, P. K.
    Hiremath, Jagdish
    Kumar, Viveka
    Shah, Mahesh K. K.
    Abdullakutty, Jabir
    Ghosh, Debasis
    Vasudevan, Karthik
    Sahoo, Panchanan
    CARDIOLOGY AND THERAPY, 2023, 12 (03) : 445 - 471
  • [2] Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists
    Jamshed Dalal
    Praveen Chandra
    Saumitra Ray
    P. K. Hazra
    Jagdish Hiremath
    Viveka Kumar
    Mahesh K. Shah
    Jabir Abdullakutty
    Debasis Ghosh
    Karthik Vasudevan
    Panchanan Sahoo
    Cardiology and Therapy, 2023, 12 : 445 - 471
  • [3] Angiotensin receptor neprilysin inhibitors in older patients with heart failure
    Sharkey, Anthony T.
    Ghafar, Mohd Zaquan
    O'Keeffe, Shaun T.
    Mulkerrin, Eamon C.
    BMJ EVIDENCE-BASED MEDICINE, 2019, 24 (01) : 5 - 7
  • [4] Initiating angiotensin receptor blockade and neprilysin inhibitor (ARNI) in acute heart failure with mechanical support
    Hsin, H. T.
    Chiu, K. M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3294 - 3294
  • [5] Combined Angiotensin Receptor/Neprilysin Inhibitors: A Review of the New Paradigm in the Management of Chronic Heart Failure
    Macdonald, Peter S.
    CLINICAL THERAPEUTICS, 2015, 37 (10) : 2199 - 2205
  • [6] Angiotensin receptor-neprilysin inhibiton (ARNI) - A novel therapeutic concept for management of hypertension and heart failure
    Kjeldsen, Sverre E.
    Hedner, Thomas
    Narkiewicz, Krzysztof
    Oparil, Suzanne
    BLOOD PRESSURE, 2012, 21 (06) : 329 - 330
  • [7] Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction
    Drazner, Mark H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (11): : 1051 - 1053
  • [8] Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
    Singh, Jagdeep S. S.
    Lang, Chim C.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 283 - 295
  • [9] LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure
    Martin P Lefkowitz
    BMC Pharmacology and Toxicology, 16 (Suppl 1)
  • [10] Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in the Treatment of Chronic Heart Failure: A Review of Landmark Trials
    Bratsos, Sosipatros
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (01)
12345